| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/14/2005 | WO2005033294A2 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage |
| 04/14/2005 | WO2005033292A2 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/14/2005 | WO2005033264A1 Methods of surface modification of-a flexible substrate to enhance cell adhesion |
| 04/14/2005 | WO2005033263A1 Circulating flow device for assays of cell cultures, cellular components and cell products |
| 04/14/2005 | WO2005033146A1 Attachment of cells to surfaces |
| 04/14/2005 | WO2005033144A2 Tim-3 polypeptides |
| 04/14/2005 | WO2005033126A1 Cell surface marker |
| 04/14/2005 | WO2005032476A2 Methods and compositions for cpg15-2 |
| 04/14/2005 | WO2005032463A2 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 04/14/2005 | WO2005032344A2 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 04/14/2005 | WO2005032341A2 Methods of evaluating oocytes for storage or reproductive treatments |
| 04/14/2005 | WO2005032245A1 Method of producing transgenic pigs expressing green fluorescent protein |
| 04/14/2005 | WO2005018663A8 G-csf derivative for inducing immunological tolerance |
| 04/14/2005 | WO2005007796A3 Improved multiwell plate |
| 04/14/2005 | WO2004113515A3 Tissue modeling in embryonic stem (es) cell system |
| 04/14/2005 | WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2005 | WO2004096990A3 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice |
| 04/14/2005 | WO2004096123A3 Methods of promoting cell viability |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation |
| 04/14/2005 | WO2004074451A3 Loading of cells with antigens by electroporation |
| 04/14/2005 | WO2004073624A3 Contraceptive methods and compositions related to proteasomal interference |
| 04/14/2005 | WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 04/14/2005 | WO2004070013A3 Use of islet 1 as a marker for isolating or generating stem cells |
| 04/14/2005 | WO2004047612A3 Methods of therapy and diagnosis |
| 04/14/2005 | WO2004037975A3 Composition and method for imaging cells |
| 04/14/2005 | WO2004034887A3 Compositions, solutions, and methods used for transplantation |
| 04/14/2005 | WO2004029208A3 Cell separation compositions and methods |
| 04/14/2005 | WO2004022764A9 Use of malate dehydrogenase for nadh regeneration |
| 04/14/2005 | WO2004020597A3 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 04/14/2005 | WO2003083069A3 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 04/14/2005 | WO2003040340A3 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 04/14/2005 | WO2003040322A3 Promoters for regulation of gene expression in plant roots |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050081268 Transgenic plant comprising luciferase sequences for use as tool in luminescent enhancement plant bioactivity |
| 04/14/2005 | US20050081263 Cholorophyllases |
| 04/14/2005 | US20050081259 Using vector comprising nucleotide sequences coding protoporphyrinogen oxidase to transform chloroplast and generate herbicide resistant plants |
| 04/14/2005 | US20050081256 Transgenic mammal comprising regulatory sequences which permit for preferential selection of sex chromosome in mammalian offspring; sex determination; tissue engineering |
| 04/14/2005 | US20050080250 Methods of stimulating growth of stromal cells in a human |
| 04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
| 04/14/2005 | US20050080240 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080232 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080027 Methods enabling the production yield of viral vectors derived from piroviruses to be improved by using DNA methylation inhibitors and/or Herpes viruses in the production of viral vectors derived from parvoviruses; suitable for transferring genes into mammalian cells, in particular into human cells |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080014 Thrombopoietic compounds |
| 04/14/2005 | US20050079616 Method of transducing ES cells |
| 04/14/2005 | US20050079612 Use of obg3 for promoting central nervous system remyelination |
| 04/14/2005 | US20050079611 Modified reconstituted basement membrane composition for assay system |
| 04/14/2005 | US20050079609 Methods and devices for the long-term culture of hematopoietic progenitor cells |
| 04/14/2005 | US20050079608 Lineage committed stem cells selected for telomerase promoter activity |
| 04/14/2005 | US20050079607 Stem cell nutrient broth comprising cell growth modulators for use regulating growth and differentiation of cells; telomerase maintenance mixtures |
| 04/14/2005 | US20050079606 Pluripotent stem cells originating in skeletal muscle intestinal tissue |
| 04/14/2005 | US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2005 | US20050079604 Method for improving functionality of tissue constructs |
| 04/14/2005 | US20050079595 Expression vector comprising nucleotide sequences coding hydrolase for use in generating enantimorphic carboxylic acid; agrochemicals and pharmeceuticals; drug design |
| 04/14/2005 | US20050079584 Modified factor VIII |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors |
| 04/14/2005 | US20050079549 Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079494 Glycinin polypeptide for use as nutrient supplement in foods |
| 04/14/2005 | US20050079488 For use in expression constructs for expressing gene products, and methods of using it |
| 04/14/2005 | US20050079487 Liquid crystals with reduced toxicity and applications thereof |
| 04/14/2005 | US20050079208 Methods of modulating antigen-specific T cell activity |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers |
| 04/14/2005 | US20050079169 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 04/14/2005 | US20050079163 Administering retroviral vector containing nucleic acid encoding a gene; antiproliferative agents; antitumor agents |
| 04/14/2005 | US20050079161 Transluminal application of adult stem cells for body organ tissue repair |
| 04/14/2005 | US20050079159 Autologous tissue for connecting structures; regeneration of tissue; cell differentiation of pluripotent cells |
| 04/14/2005 | CA2814613A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2776997A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 04/14/2005 | CA2541006A1 Tim-3 polypeptides |
| 04/14/2005 | CA2540681A1 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 04/14/2005 | CA2540672A1 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 04/14/2005 | CA2540622A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 04/14/2005 | CA2540253A1 Hiv-dependent expression constructs and uses therefor |
| 04/14/2005 | CA2540244A1 Methods and compositions for defining gene function |
| 04/14/2005 | CA2538918A1 Process for producing intermediate of useful alkaloid biosynthesis according to rnai method |
| 04/14/2005 | CA2537997A1 Methods of surface modification to enhance cell adhesion |
| 04/14/2005 | CA2537994A1 Methods of surface modification of a flexible substrate to enhance cell adhesion |
| 04/14/2005 | CA2537318A1 Method of repairing primate mammalian tissue |
| 04/14/2005 | CA2527700A1 Stem cells for clinical and commercial uses |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 04/13/2005 | EP1522578A1 Transferring materials into cells using porous silicon |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |